New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
08:37 EDTISISIsis shares can advance following recent weakness, says BMO Capital
After meeting with Isis' CEO, BMO Capital thinks the stock can rise significantly after the company reports data on its antisense drugs. The firm expects data for a number of the company's antisense drugs to be positive, and it keeps a $70 price target and Outperform rating on the shares.
News For ISIS From The Last 14 Days
Check below for free stories on ISIS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
07:29 EDTISISIsis Pharmaceuticals earns $4M from Achaogen for Phase 3 study of plazomicin
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use